Intuitive Surgical price target raised to $650 from $625 at RBC Capital

RBC Capital analyst Shagun Singh raised the firm’s price target on Intuitive Surgical (ISRG) to $650 from $625 and keeps an Outperform rating on the shares as part of a broader research note previewing 2026 for Medical Supplies & Devices. The firm anticipates a year of positive momentum as sector fundamentals are solidly intact driven by the aging demographics, growing global healthcare access, and differentiated innovation, the analyst tells investors in a research note. For the company, RBC says it continues to garner positive feedback on dV5, including improvements in precision, imaging, ergonomics, and integration, all of which are improving efficiency.